These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25066135)

  • 21. Protein-Protein Docking Approach to GPCR Oligomerization.
    Khylyuk D
    Methods Mol Biol; 2024; 2780():281-287. PubMed ID: 38987473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?
    Kapla J; Rodríguez-Espigares I; Ballante F; Selent J; Carlsson J
    PLoS Comput Biol; 2021 May; 17(5):e1008936. PubMed ID: 33983933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of template choice on homology model efficiency in virtual screening.
    Rataj K; Witek J; Mordalski S; Kosciolek T; Bojarski AJ
    J Chem Inf Model; 2014 Jun; 54(6):1661-8. PubMed ID: 24813470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
    Cross JB
    Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPCR-ModSim: A comprehensive web based solution for modeling G-protein coupled receptors.
    Esguerra M; Siretskiy A; Bello X; Sallander J; Gutiérrez-de-Terán H
    Nucleic Acids Res; 2016 Jul; 44(W1):W455-62. PubMed ID: 27166369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPCR homology model template selection benchmarking: Global versus local similarity measures.
    Castleman PN; Sears CK; Cole JA; Baker DL; Parrill AL
    J Mol Graph Model; 2019 Jan; 86():235-246. PubMed ID: 30390544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of ligand type and receptor activation state.
    Thomas BN; Parrill AL; Baker DL
    J Mol Graph Model; 2022 May; 112():108119. PubMed ID: 34979368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection.
    Liessmann F; Künze G; Meiler J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPCR agonist binding revealed by modeling and crystallography.
    Katritch V; Abagyan R
    Trends Pharmacol Sci; 2011 Nov; 32(11):637-43. PubMed ID: 21903279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural modeling of G-protein coupled receptors: An overview on automatic web-servers.
    Busato M; Giorgetti A
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt B):264-74. PubMed ID: 27102413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova.
    Ciancetta A; Cuzzolin A; Deganutti G; Sturlese M; Salmaso V; Cristiani A; Sabbadin D; Moro S
    Mol Inform; 2016 Sep; 35(8-9):440-8. PubMed ID: 27546048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.